Clinical Roundup PATH tool and study reveal cancer cells “shape-shift” to evade treatment October 04, 2024Vol.50 No.37
Clinical Roundup Crofelemer relieves diarrhea in breast cancer subgroup in phase III trial October 04, 2024Vol.50 No.37
Clinical Roundup UT Health San Antonio creates pancreatic cancer organoid October 04, 2024Vol.50 No.37
Clinical Roundup Barcode technology could help diagnose cancer more precisely October 04, 2024Vol.50 No.37
Clinical Roundup Xcell Biosciences, AmplifyBio expand collaboration with cell and gene therapy manufacturing capabilities October 04, 2024Vol.50 No.37
Clinical Roundup First-in-human study of novel inhibitor shows promise in MTAP-deleted solid tumors October 04, 2024Vol.50 No.37
Clinical Roundup Perjeta biosimilar safe and effective for breast cancer in phase III trial October 04, 2024Vol.50 No.37
Drugs & Targets FDA approves neoadjuvant/adjuvant Opdivo for resectable NSCLC October 04, 2024Vol.50 No.37
Drugs & Targets FDA approves Retevmo for medullary thyroid cancer with RET mutation October 04, 2024Vol.50 No.37
